ArticleCancer immunology, immunotherapy : CII2015

Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment.

Urban Švajger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.